ClinicalTrials.gov
ClinicalTrials.gov Menu

Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00156871
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : January 19, 2012
Sponsor:
Collaborator:
Alberta Cancer Foundation
Information provided by:
AHS Cancer Control Alberta

Brief Summary:
The purpose of this study is to investigate the impact of fatigue in severely affected transplant patients.

Condition or disease Intervention/treatment Phase
Fatigue Behavioral: exercise Not Applicable

Detailed Description:
Investigates impact of a monitored program in kinesiology lab at the University of Calgary on fatigue in severely affected transplant patients.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 24 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant
Study Start Date : April 2003
Actual Study Completion Date : December 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Fatigue score


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Severe fatigue post transplant

Exclusion Criteria:

  • Other conditions contributing to fatigue (graft versus host disease)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00156871


Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
Alberta Health Services
Alberta Cancer Foundation
Investigators
Study Director: James Russell AHS Cancer Control Alberta
Principal Investigator: Nicole Colos-Reed, Phd University of Calgary

ClinicalTrials.gov Identifier: NCT00156871     History of Changes
Other Study ID Numbers: 181710-DRD 16
ACF 717905155
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: January 19, 2012
Last Verified: August 2011

Keywords provided by AHS Cancer Control Alberta:
transplant
fatigue
exercise
Malignant disease

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms